Simplified Treatment of Acute Lower Respiratory Tract Infection with Azithromycin: A Comparison with Erythromycin and Amoxycillin

Journal of International Medical Research

Volumn 19, Issue 5, 1991, Pages 373-383

  Daniel, R ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

amoxicillin; Azithromycin; bronchitis; erythromycin; pneumonia

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; ERYTHROMYCIN STEARATE;

ACUTE DISEASE; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HAEMOPHILUS INFLUENZAE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; NAUSEA; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; AZITHROMYCIN; BACTERIAL INFECTIONS; BRONCHITIS; COMPARATIVE STUDY; ERYTHROMYCIN; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMAN; MALE; MIDDLE AGE; PNEUMOCOCCAL INFECTIONS; PNEUMONIA; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0025909178     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006059101900503     Document Type: Article

References (12)

1. Fiese EF Steffen SH Comparison of the acid stability of azithromycin and erythromycin. J Antimicrob Chemother 1990; 25 (suppl A): 39–47.
2. Foulds G Shephard RM Johnson RB The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25 (suppl A): 73–82.
3. Gladue RP Bright GM Isaacson RE In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: Possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989; 33: 277–282.
4. Gladue RP Snider ME Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 1990; 34: 1056–1060.
5. Baldwin DR Wise R Andrews JM Azithromycin concentrations at the sites of pulmonary infection. Eur Respir J 1990; 3: 886–890.
6. Davies B Maesen FPV Gubbelmans R Azithromycin (CP-62,993) in acute exacerbations of chronic bronchitis: An open clinical, microbiological and pharmacological study. J Antimicrob Chemother 1989; 23: 743–751.
7. Retsema J Girard A Schelkley W Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrob Agents Chemother 1987; 31: 1939–1947.
8. Rylander M Hallander HO In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP-62,933, agonist Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Scand J Infect Dis 1988; 53: 12–17.
9. Fitzgeorge RB Featherstone ASR Baskerville A Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol. J Antimicrob Chemother 1990; 25: 101–108.
10. Chirgwin K Roblin PM Hammerschlag MR In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrob Agents Chemother 1989; 33: 1634–1635.
11. Fenelon LE Mumtaz G Ridgway The in vitro antibiotic susceptibility of Chlamydia pneumoniae. J Antimicrob Chemother 1990; 26: 763–767.
12. Dunkin KT Jones S Howard AJ The in vitro activity of CP-62.993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci. J Antimicrob Chemother 1988; 21: 405–411.